Xu Y - Search Results

1

Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer.

Balint JP, Gabitzsch ES, Rice A, Latchman Y, Xu Y, Messerschmidt GL, Chaudhry A, Morse MA, Jones FR. Balint JP, et al. Among authors: xu y. Cancer Immunol Immunother. 2015 Aug;64(8):977-87. doi: 10.1007/s00262-015-1706-4. Epub 2015 May 9. Cancer Immunol Immunother. 2015. PMID: 25956394 Free PMC article. Clinical Trial.

2

An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice.

Gabitzsch ES, Xu Y, Balcaitis S, Balint JP Jr, Jones FR. Gabitzsch ES, et al. Among authors: xu y. Cancer Gene Ther. 2011 May;18(5):326-35. doi: 10.1038/cgt.2010.82. Epub 2011 Jan 14. Cancer Gene Ther. 2011. PMID: 21233857 Free PMC article.

3

A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses.

Gabitzsch ES, Xu Y, Yoshida LH, Balint J, Gayle RB, Amalfitano A, Jones FR. Gabitzsch ES, et al. Among authors: xu y. Immunol Lett. 2009 Jan 29;122(1):44-51. doi: 10.1016/j.imlet.2008.11.003. Epub 2008 Dec 13. Immunol Lett. 2009. PMID: 19073216 Free PMC article.

4

Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA.

Gabitzsch ES, Xu Y, Balint JP Jr, Hartman ZC, Lyerly HK, Jones FR. Gabitzsch ES, et al. Among authors: xu y. Cancer Immunol Immunother. 2010 Jul;59(7):1131-5. doi: 10.1007/s00262-010-0847-8. Epub 2010 Apr 2. Cancer Immunol Immunother. 2010. PMID: 20361185 Free PMC article.

5

Induction and comparison of SIV immunity in Ad5 naïve and Ad5 immune non-human primates using an Ad5 [E1-, E2b-] based vaccine.

Gabitzsch ES, Xu Y, Balint JP Jr, Balcaitis S, Sanders-Beer B, Jones FR. Gabitzsch ES, et al. Among authors: xu y. Vaccine. 2011 Oct 19;29(45):8101-7. doi: 10.1016/j.vaccine.2011.08.038. Epub 2011 Aug 22. Vaccine. 2011. PMID: 21864618 Free PMC article.

6

Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients.

Morse MA, Chaudhry A, Gabitzsch ES, Hobeika AC, Osada T, Clay TM, Amalfitano A, Burnett BK, Devi GR, Hsu DS, Xu Y, Balcaitis S, Dua R, Nguyen S, Balint JP Jr, Jones FR, Lyerly HK. Morse MA, et al. Among authors: xu y. Cancer Immunol Immunother. 2013 Aug;62(8):1293-301. doi: 10.1007/s00262-013-1400-3. Epub 2013 Apr 30. Cancer Immunol Immunother. 2013. PMID: 23624851 Free PMC article. Clinical Trial.

7

Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity.

Gabitzsch ES, Xu Y, Yoshida LH, Balint J, Amalfitano A, Jones FR. Gabitzsch ES, et al. Among authors: xu y. Vaccine. 2009 Oct 30;27(46):6394-8. doi: 10.1016/j.vaccine.2009.06.028. Epub 2009 Jun 24. Vaccine. 2009. PMID: 19559110 Free PMC article.

8

Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine.

Jones FR, Gabitzsch ES, Xu Y, Balint JP, Borisevich V, Smith J, Smith J, Peng BH, Walker A, Salazar M, Paessler S. Jones FR, et al. Among authors: xu y. Vaccine. 2011 Sep 16;29(40):7020-6. doi: 10.1016/j.vaccine.2011.07.073. Epub 2011 Aug 5. Vaccine. 2011. PMID: 21821082 Free PMC article.

9

Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform.

Gabitzsch ES, Balint-Junior JP, Xu Y, Balcaitis S, Sanders-Beer B, Karl J, Weinhold KJ, Paessler S, Jones FR. Gabitzsch ES, et al. Among authors: xu y. Vaccine. 2012 Nov 26;30(50):7265-70. doi: 10.1016/j.vaccine.2012.09.058. Epub 2012 Oct 2. Vaccine. 2012. PMID: 23041546 Free PMC article.

10

A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors.

Wieking BG, Vermeer DW, Spanos WC, Lee KM, Vermeer P, Lee WT, Xu Y, Gabitzsch ES, Balcaitis S, Balint JP Jr, Jones FR, Lee JH. Wieking BG, et al. Among authors: xu y. Cancer Gene Ther. 2012 Oct;19(10):667-74. doi: 10.1038/cgt.2012.55. Epub 2012 Aug 24. Cancer Gene Ther. 2012. PMID: 22918471 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,088 results

Search Page

Filters